您现在的位置是:【微信950216】银河客服电话 > 知识
Weight regain happens 4x faster after stopping GLP
【微信950216】银河客服电话2026-01-31 22:49:20【知识】5人已围观
简介Facebook TwitterThreads FlipboardCommentsPrintEmailAdd Fox News on GoogleWeigh
- Threads
- Comments
- Add Fox News on Google
Weight-loss journeys can cause social strains for GLP-1 patients, doctor says
Dr. Rocio Salas-Whalen shares how rapid GLP-1–driven weight reductions leave many individuals confronting psychological challenges that complicate relationships and social routines.
NEWYou can now listen to Fox News articles!Discontinuing the use of GLP-1 weight-loss medications triggers weight regain more than previously thought, a new study suggested.
The research, which was published in The BMJ, found that stopping the drugs is also associated with a reversal of improvements in heart and metabolic health, including cholesterol and blood pressure.
University of Oxford researchers analyzed 37 studies published up to February 2025, involving more than 9,000 participants who had undergone an average of 39 weeks of weight-loss treatment.
OLDER AMERICANS ARE QUITTING GLP-1 WEIGHT LOSS DRUGS FOR 4 KEY REASONS
On average, patients regained about 0.9 pounds per month after stopping treatment. Researchers estimated that body weight and risk markers for diabetes and heart disease would return to pre-treatment levels in less than two years.

On average, patients regained about 0.9 pounds per month after stopping treatment. (iStock)
The analysis also revealed that the weight came back on nearly four times faster than after changing or quitting a diet or exercise regimen, no matter how many pounds had been shed.
OBESITY EXPERT REVEALS THE BEST WAY TO DECIDE IF GLP-1S ARE RIGHT FOR YOU
"The evidence suggests that despite their success in achieving initial weight loss, these drugs alone may not be sufficient for long-term weight control," the researchers commented in a press release.
CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER
The study authors acknowledged that only eight studies assessed treatment with newer GLP-1 drugs, at a maximum follow-up period of 12 months after the medication was stopped. This could serve as a limitation, although three additional methods of analysis provided similar results.

These findings question the effectiveness of GLP-1s for long-term weight loss, the researchers noted. (iStock)
In an editorial responding to the study, Dr. Qi Sun, associate professor of medicine at Brigham and Women’s Hospital and Harvard Medical School, wrote that these findings "cast doubt" on the idea that GLP-1s are a "perfect cure for obesity."
CLICK HERE FOR MORE HEALTH STORIES
"People taking GLP-1 receptor agonists should be aware of the high discontinuation rate and the consequences of cessation of medications," he said. "Healthy dietary and lifestyle practices should remain the foundation for obesity treatment and management, with medications such as GLP-1 receptor agonists used as adjuncts."
"Many of the patients who quit their GLP-1 drugs could have stayed on them with the right personalized care."
很赞哦!(695)
上一篇: 中国马术协会选派2019年全国速度赛马锦标赛裁判员
下一篇: 中国古代名人故事:古代名人王羲之
相关文章
- 《TerraMystica》PC版下载 Steam正版分流下载
- 勇闯女巫塔魔女抽取攻略 勇闯女巫塔魔女抽取怎么避坑
- 冬季测试YU7表现如何?雷军宣布:五项第一,综合电耗低于特斯拉
- 《羊蹄山之魂》女主角笃雕像即将开售 很还原
- 《超女》曝官方前导预告 2026年6月北美上映
- 闵行这个安置房小区启动交付 1000多户居民将在年底前完成入户手续
- 芜湖市:“爱心三件套”温暖学子求学路
- 淮南市:剪除“空中蛛网” 扮靓城市“天际线”
- 零厨艺也能做好的意头菜:香辣竹签虾
- ผบก.ตม.5 สั่งตั้ง กก.สอบข้อเท็จจริงปม จนท.ตม.ตาก ส่งผู้ต้องสงสัยคดีฆ่าผู้อื่นกลับเมียนมาร์
热门文章
站长推荐
友情链接
- 《剑网3》十六周年庆发布会:“全民新流派+沉浸式剧情前传”续写大唐江湖!
- 我开了20年大巴,现在是一名西甲主帅
- 央视曝光AI培训“月入过万”骗局 专坑老年人
- 五年级数学天天练试题及答案2023.11.30(周期性问题)
- 二年级数学天天练试题及答案2023.12.7(找规律)
- 我开了20年大巴,现在是一名西甲主帅
- 无尽探险队职业流派推荐攻略
- COC总决赛衢州柯城站预赛战罢 年度争冠即将上演 车队
- 雷索纳斯角色强度榜一览2026
- 冰箱冷冻食物千万注意的禁忌
- 《最美的回忆》(六哲演唱)的文本歌词及LRC歌词
- 怀特33+5+6韦尔24+14 凯尔特人末节发力扑灭热火
- 法师PK技巧大揭秘:战胜战士与道士的实战策略
- เปิดข้อมูลชุดใหม่ พบแนวควบคุมของอิสราเอลลึกเข้าไปในฉนวนกาซากว่าที่คาด
- 玫瑰养颜粽、山楂纤体粽……听名字你馋了吗?沪上中医院端午前夕推出养生粽
- เสียงชาวบ้านในพื้นที่สีเหลือง หลังชายแดนไทย
- Sếp bự tức giận dù Real Madrid 2
- 武切维奇24+15加兰35+8 阿伦14+12公牛送骑士三连败
- 谷歌输入法怎么手写输入
- 不锈钢模具冲压花盆生产工艺流程







